CBD for headaches and migraines: is it worth trying and how to use it.
Does CBD help with headaches and migraines? A randomized study found no advantage of CBD over placebo. Check how to plan a trial and when to see a doctor.
15.8 percent of people worldwide experience headaches every day, and active headache disorders affect 52 percent of the population (Stovner et al., The Journal of Headache and Pain, 2022). Given this scale, every promise of relief finds an audience, and cannabidiol has occupied a place in search engines as a ready answer for several years. The title of this text promises two things: an assessment of whether it's worth trying and instructions for use. The second part is uncomfortable because no one has established CBD dosages for headaches. Below you will find what can be said honestly: what the first randomized study showed, how headache types differ, which symptoms require urgent diagnostics, and how to plan your own trial.
KEY INFORMATION
• The CBD-dominant arm did not outperform placebo in migraine attacks: 53 versus 47 percent relief after two hours (Schuster et al., Headache, 2026).
• The advantage was only shown by the combination of THC with cannabidiol, which is a preparation different from the oil from the store.
• CBD dosages for headaches have not been established in any study, so ready-made protocols are made up.
• 30 mg of CBD raised the concentration of amitriptyline, a preventive medication for migraines and tension-type headaches (Gorbenko et al., 2026).
• A sudden, worst headache of your life is a reason for urgent diagnostics.
Does CBD alleviate headaches and migraines?
There is no evidence for this. In the first randomized study of cannabis for acute migraine attacks, the cannabidiol-dominant arm did not perform better than placebo in any of the three endpoints measured after two hours (Schuster i wsp., Headache, 2026).
The study included 92 participants who treated up to four attacks, each time with a different preparation, in an alternating design with a double-blind trial. Vaporized flower with 6 percent THC, flower with 11 percent CBD, a combination of both, and placebo in the form of cannabinoid-free flower were compared. Of the 247 recorded attacks, relief after two hours was achieved in 67 percent of those treated with the combination of THC and CBD, in 69 percent after THC alone, in 53 percent after CBD-rich flower, and in 47 percent after placebo. Only the first two results were statistically significant.
The distinction that arises from this determines the rest of the text. Cannabidiol and cannabis are not synonyms. The flower contains dozens of cannabinoids, primarily THC, which is a psychoactive substance with a different receptor profile. When a study shows that vaporizing cannabis shortens an attack, it refers to cannabis with THC, not a bottle of oil.
The lack of evidence of effectiveness is not the same as evidence of lack of effectiveness. No one has conducted a study for oral CBD in migraine prevention that could resolve the matter in either direction. For tension-type headaches, there isn't even that.
What type of headache do you have and why does it change the answer?
Because studies on cannabis have focused on migraines, and migraines are a minority of headaches. Globally, migraines affect 14 percent of people, tension-type headaches 26 percent, and headaches for 15 or more days a month 4.6 percent (Stovner et al., The Journal of Headache and Pain, 2022).
| Type of headache | How it manifests | What has documented effectiveness |
|---|---|---|
| migrena | unilateral, pulsating, lasts from 4 to 72 hours, worsens with movement, with nausea or photophobia | tryptany w napadzie, profilaktyka lekowa, magnez, ryboflawina |
| tension-type headache | bilateral, pressing, non-pulsating, does not worsen with movement | amitriptyline 100 mg, chronic botulinum toxin |
| pain from medication overuse | 15 or more days with pain in a month with frequent acute medications | odstawienie leku i profilaktyka pod nadzorem lekarza |
| secondary pain | symptom of another disease, usually with an alarm signal from the list below | diagnosis of the cause, often urgent |
In the prevention of chronic tension-type headache, a network meta-analysis of 35 randomized studies ranked amitriptyline 100 mg highest, which reduced the number of days with pain by more than six per month (Tao i wsp., Annals of Medicine, 2026). Cannabidiol is not included in this ranking due to a lack of studies for inclusion. If you do not have a diagnosis from a doctor, the first step is to obtain one, not to choose a product.
When does a headache require urgent diagnosis instead of a supplement?
When a feature indicating secondary pain appears, meaning a symptom of another disease. A set of such alarm signals has been compiled in the SNNOOP10 list, developed to increase the chances of detecting headaches with a cause requiring immediate action (Do i wsp., Neurology, 2019).
| Warning signal | What can it mean |
|---|---|
| sudden pain reaching its peak in seconds, the strongest in life | subarachnoid hemorrhage, arterial dissection |
| fever with neck stiffness | meningitis or encephalitis |
| neurological deficit or altered consciousness | udar, guz, proces uciskowy |
| pain that appeared after a head injury | intracranial hematoma |
| the first severe headache in life after the age of 50 | giant cell arteritis, intracranial lesion |
| change in the previous character of pain, increasing from week to week | neoplastic process, intracranial hypertension |
The first item on this list is an emergency situation, not a reason to wait. The same applies to pain with fever and neck stiffness, as well as any pain with a persistent neurological deficit. In these scenarios, the appropriate solution is the emergency number, and oil has no role here. Separately, it is worth counting the days in a month when you reach for any pain medication or triptan. If it exceeds ten, prioritizing a visit to the doctor is essential, as such a pattern perpetuates headache.
How much CBD to take for a headache?
No one has established this dose. There is no clinical study comparing oral cannabidiol doses in migraine or tension-type headache, so any protocol like 'start with 10 mg and increase every three days to 60 mg' comes from the author of the text or from a seller, not from the literature.
The only dose actually tested in migraine was inhaled: vaporized flower with 11 percent cannabidiol, administered once during an attack. This variant did not outperform placebo. Transferring it to sublingual drops has no basis, as the route of administration changes pharmacokinetics.
It is not even known how much cannabidiol from the oil enters the bloodstream. A systematic review of the pharmacokinetics of CBD in humans found only 24 studies with such data, and absolute bioavailability was measured only for smoking, which was 31 percent (Millar et al., Frontiers in Pharmacology, 2018). No such values have been established for oral and sublingual administration. The figures "13 to 19 percent," attributed online to this review, do not appear in the original.
This has practical consequences. The maximum concentration after ingestion occurs within a window of up to four hours, so you cannot plan to take the oil "at the first signs of an attack" with reasonable precision. We discuss routes of administration in the text about this, on how to take CBD.
How to plan a CBD trial so that its result means anything?
Establish an assessment criterion before the first dose, otherwise you will evaluate your mood rather than the effect of the product. In studies on migraine prevention, success is usually defined as a reduction in the number of days with pain by at least 30 percent after 8 to 12 weeks. This is a reasonable threshold for a self-conducted trial.
Start with a month of observation without any changes. Record the date of the attack, duration, intensity on a scale from 0 to 10, and each day you reached for an as-needed medication. Only with such a base, introduce one thing at a time. If you start cannabidiol, magnesium, and a new sleep rhythm simultaneously, after two months you won’t learn anything about any of them.
Write down the date of your decision in advance and stick to it. After eight, at most twelve weeks, compare the number of days with headaches to the baseline month. If the decrease is less than 30 percent, that is your answer. Increasing the dose just in case has no basis here, as no relationship between dose and response has been measured for cannabidiol in headaches.
Our observations from conversations with readers: the most commonly overlooked entry in such a journal is the number of days with as-needed medication, and it is this that carries the most information. Those who report "milder attacks" with an unchanged number of days with the pill usually describe a change in well-being, not the course of the disease.
Does CBD interact with headache medications?
One interaction has been measured in humans and concerns amitriptyline. A single dose of 30 mg of cannabidiol increased the area under the curve of amitriptyline concentration by 13 percent and the maximum concentration by 17 percent in healthy volunteers (Gorbenko i wsp., British Journal of Clinical Pharmacology, 2026).
This is actually the most practical result from all the literature, as amitriptyline is a preventive medication for migraines and is also the highest-rated option for chronic tension-type pain. Therefore, it concerns both groups of people looking for cannabidiol for headaches. The study involved 13 participants, and the effect was moderate. The concentration of tramadol did not change, which shows that the inhibition of metabolism does not work the same for all medications.
The mechanistic background has been known for years: cannabidiol inhibits several isoenzymes of cytochrome P450 and affects drug transporters (Iffland and Grotenhermen, Cannabis and Cannabinoid Research, 2017). No one has studied triptans in combination with CBD, so we must infer from pharmacology.
The adverse effects of cannabidiol are well documented. A meta-analysis of four randomized studies involving 269 healthy adults showed that after CBD, the risk of diarrhea was nearly six times higher than after placebo, and there was a statistically insignificant trend towards more frequent headaches (Sawaira i wsp., Annals of Medicine and Surgery, 2026).
Where did the belief that CBD works for migraines come from?
From three sources, none of which is a study of cannabidiol itself in people with migraines. The first is a hypothesis, the second is a conference report about an extract containing THC, and the third is an observation of users of inhaled cannabis.
The clinical endocannabinoid deficiency hypothesis suggests that in some patients, the baseline tension of the endocannabinoid system is lowered, which explains treatment-resistant pain syndromes. Its author refers to it as a theory and a hypothesis, not an established fact (, 2016). The hypothesis suggests that migraine, fibromyalgia, and irritable bowel syndrome may result from reduced ECS tone., 2016). Even if it were confirmed, cannabidiol is not anandamide and does not directly stimulate cannabinoid receptors.
The Italian report by Nicolodi, cited in Polish internet as a study, was a presentation at the European Academy of Neurology congress in 2017. It did not undergo peer review, was not indexed as a full paper, and concerned an extract of THC, not oil with cannabidiol.
The third source is an analysis of data from an app where users recorded symptoms before and after using cannabis: 12,293 sessions with headaches and 7,441 with migraines (Cuttler i wsp., The Journal of Pain, 2020). There was no control group, and inhaled cannabis was studied. The involvement of the endocannabinoid system in trigeminal nociception is real and well described (Greco i wsp., Frontiers in Neuroscience, 2018), but it describes a pharmacological target, not the effectiveness of a store-bought product. You can find a detailed breakdown of these studies in the text about this, what studies say about CBD for migraines.
Where to start, since CBD has such weak evidence?
From diagnosis, and then from options that have undergone placebo-controlled studies. This is practically the most important part of this article, as it concerns money and time, which can easily be spent in the wrong order.
Magnesium has undergone randomized placebo-controlled studies and has made it into national and international recommendations as an option in the prevention of headaches and migraines (Maier et al., Nutrients, 2020). Riboflavin, or vitamin B2, has been the subject of a meta-analysis of 12 clinical studies involving 749 people and reduced the number of attacks by an average of 1.39 per month, with a dose-dependent effect up to 400 mg per day (Amini i wsp., Journal of Research in Medical Sciences, 2026). The heterogeneity between studies was high, so read the result cautiously, but this is a different league of evidence than a series of cases.
Additionally, there are triptans for migraine attacks, prevention prescribed by a neurologist, and amitriptyline for chronic tension-type pain. You can find magnesium and B vitamin preparations in the category supplements. This is not about discouraging cannabidiol, but about the order: starting with a product without evidence is a costly roundabout way.
Frequently Asked Questions
Does CBD help with headaches?
There is no evidence for this. In the first randomized study of cannabis in acute migraine, the CBD-dominant arm provided relief after two hours in 53 percent of attacks compared to 47 percent after placebo, and the difference was not statistically significant (Schuster i wsp., Headache, 2026). The advantage was only shown with the combination of THC and cannabidiol.
How much CBD to take for migraines?
No one has established this dosage. There is no clinical study comparing oral cannabidiol doses in migraine or tension-type headache, so ready-made protocols like "start with 10 mg and increase every three days" are made up. The only dose tested in migraine was inhaled and did not outperform placebo.
Does CBD help with tension-type headaches?
No such study has been conducted, so there simply is no answer. In the prevention of chronic tension-type headache, the highest-rated option in a network meta-analysis of 35 randomized studies was amitriptyline at a dose of 100 mg (Tao i wsp., Annals of Medicine, 2026). Cannabidiol does not appear in this comparison.
Can CBD be combined with headache medications?
One interaction has been measured in humans. A single dose of 30 mg CBD raised the concentration of amitriptyline in the plasma of healthy volunteers (Gorbenko i wsp., British Journal of Clinical Pharmacology, 2026). Amitriptyline is a preventive medication for migraine and tension-type headache, so consult such a combination with your healthcare provider.
When does a headache require urgent medical attention?
When pain appears suddenly and is the worst of your life, accompanied by fever with neck stiffness or neurological deficit, when it occurred after a head injury, when it is the first severe pain after the age of 50, or when it changes its usual character. These signals have been compiled on the SNNOOP10 list (Do i wsp., Neurology, 2019).
Can CBD itself cause headaches?
A meta-analysis of four randomized studies involving 269 healthy adults showed that after CBD, diarrhea occurred significantly more often and there was a statistically insignificant trend towards more frequent headaches (Sawaira i wsp., Annals of Medicine and Surgery, 2026). A separate risk is headache from overuse of acute medications.
Olejki konopne z certyfikatami analizy znajdziesz w kategorii oils.
This article is for informational and educational purposes and does not constitute medical advice. Before starting to use cannabis or CBD for therapeutic purposes, consult a doctor, especially if you are taking other medications, are pregnant, or breastfeeding.
Author: Michał Waluk · Opublikowano: 2026-06-22 · Aktualizacja: 2026-08-08
